Key facts
- This page summarizes Glenn A. Eisenberg's Form 4 filing for LABCORP HOLDINGS INC. (LH).
- 5 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 04 Dec 2024, 09:59.
Glenn A. Eisenberg - 02 Dec 2024 Form 4 Insider Report for LABCORP HOLDINGS INC. (LH)
- Reporting relationship
- Executive Vice President
- Issuer ticker
- LH
- Reported as of
- 02 Dec 2024
- Net transaction value
- -$330,497
- SEC form
- 4
- Accepted by SEC
- 04 Dec 2024, 09:59:45 UTC
- Prior SEC filing
- 19 Aug 2024
- Next SEC filing
- 10 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Sandra D. van der Vaart, Attorney-in-Fact for Glenn A. Eisenberg
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Glenn A. Eisenberg filed Form 4 for LABCORP HOLDINGS INC. (LH) on 04 Dec 2024.
Change
- Previous filing in this sequence was filed on 19 Aug 2024.
- Current net transaction value: -$330,497.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LH
transaction
Common Stock
Options Exercise
- Transaction value
- $1,867,138
- Shares
- +8,923
- Change %
- +29%
- Price
- $209.25
- Shares after
- 40,212
- Date
- 02 Dec 2024
- Ownership
- Direct
LH
transaction
Common Stock
Options Exercise
- Transaction value
- $618,016
- Shares
- +2,788
- Change %
- +6.9%
- Price
- $221.67
- Shares after
- 43,000
- Date
- 02 Dec 2024
- Ownership
- Direct
LH
transaction
Common Stock
Sale
- Transaction value
- $2,815,651
- Shares
- -11,711
- Change %
- -27%
- Price
- $240.43
- Shares after
- 31,289
- Date
- 02 Dec 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
LH
transaction
Derivative
Non-qualified Stock Options
Options Exercise
- Transaction value
- $0
- Shares
- -8,923
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 02 Dec 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,923
- Exercise price
- $209.25
- Footnotes
- F2, F3, F4
LH
transaction
Derivative
Non-qualified Stock Options
Options Exercise
- Transaction value
- $0
- Shares
- -2,788
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 5,577
- Date
- 02 Dec 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,788
- Exercise price
- $221.67
- Footnotes
- F2, F3, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
The price of $240.4279 per share represents a weighted average of sales prices ranging from $240.015 to $240.94 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
Footnote F2
Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan.
Footnote F3
Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Labcorp Holdings Inc. ("LHI"), calculated pursuant to the terms of the Employee Matters Agreement by and between LHI and Fortrea.
Footnote F4
The option vested in three equal annual installments beginning on the date reflected in this column.
Footnote F5
The option vests in three equal annual installments beginning on the date reflected in this column.